Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07586995 · ClinicalTrials.gov registry record
A Post-Market Assessment of the Safety and Performance of the TriClip™ System
A clinical trial, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07586995 is a clinical trial that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 1,000 participants.
The verdict
NCT07586995 is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
Interventions
- DEVICE Tricuspid Transcatheter Edge-to-Edge Repair (TEER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2033-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07586995
The ClinicalTrials.gov registry entry for NCT07586995 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tricuspid Transcatheter Edge-to-Edge Repair (TEER) is the first listed.
NCT07586995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07586995 about?
NCT07586995 is a clinical study titled "A Post-Market Assessment of the Safety and Performance of the TriClip™ System". The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
What is the current status of trial NCT07586995?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-06. Estimated completion is 2033-08.
What interventions are being tested in trial NCT07586995?
The interventions under investigation include: Tricuspid Transcatheter Edge-to-Edge Repair (TEER) (DEVICE).
Who is sponsoring clinical trial NCT07586995?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.